NCT02639936 - New Generation IGRA in Immunocompromised Individuals | Biotech Hunter

Enrollment

2,663

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Monitoring, ImmunologicActive TuberculosisTuberculosis in Solid Organ Transplant RecipientsTuberculosis in Marrow Transplant RecipientsTuberculosis in Rheumatoid ArthritisTuberculosis in Chronic Renal FailureTuberculosis in HIV-infected Individuals

Trial Locations (16)

5

Marius Nasta Institute of Pneumology, Bucharest

2004

Department of Pneumology & Allergology, Chisinau

2100

Rigshospitalet, Copenhagen

20132

San Raffaele Scientific institute, Milan

33001

Hospital Universitario Central de Asturias, Oviedo

66421

Saarland University, Homburg

79100

Freiburg University, Freiburg im Breisgau

Unknown

Research center Borstel, Borstel

University of Brescia and Brescia Spedali Civili General Hospital, Brescia

Centro de Diagnóstico Pneumológico, Vila Nova de Gaia

00149

National Institute for Infectious Diseases L. Spallanzani, Rome

0450

Department of Infectious Diseases; Oslo University, Oslo

02-097

Warszawski Uniwersytet Medyczny, Warsaw

08916

Institut d'Investigació Germans Trias i Pujol, Badalona

08001

Hospital Universitari Vall d'Hebron, Barcelona

NW3 2QG

Department of Respiratory Medicine, Royal Free Hospital, London

All Listed Sponsors

lead

Tuberculosis Network European Trialsgroup

NETWORK